Ophthalmology prior authorization at Highmark
PA workflow, documentation criteria, and peer-to-peer prep — for prescribers and PA staff
Highmark ophthalmology PA at a glance
Highmark reviews ophthalmology PA submissions against its medical policy library, with rules drawn primarily from AAO (American Academy of Ophthalmology) Preferred Practice Patterns. Highmark-specific context: Operates BCBS in PA (western), WV, DE, NY (western). Owns Allegheny Health Network.
Documentation packet — what to send
- Diagnosis with ICD-10 (nAMD, DME, RVO, mCNV)
- OCT scan with central macular thickness
- Fluorescein angiography or OCT-A confirming CNV/leakage where required
- Prior anti-VEGF history (drug, doses, intervals, response)
- Visual acuity (Snellen + ETDRS letters)
Common denial patterns to pre-empt
Patterns observed in ophthalmology across payers, and where Highmark's book of business overlaps:
- Anti-VEGF: brand vs compounded bevacizumab (significant cost differential)
- Step therapy: bevacizumab before aflibercept/faricimab
- Dosing interval not policy-compliant (e.g., monthly vs every-8-weeks)
- Diagnosis confirmation (OCT, fluorescein angiogram) not documented
- Loading dose schedule not followed
Appeal angles when Highmark denies
- AAO Preferred Practice Pattern citation
- Anatomic outcome (OCT central macular thickness)
- Functional outcome (visual acuity by ETDRS letters)
- Documented prior anti-VEGF failure
- Diabetic macular edema vs neovascular AMD vs RVO — distinct PA criteria per indication
Peer-to-peer prep
- Bring the latest OCT scan (printed or open in EHR)
- Quote the AAO PPP by year + indication
- For step-therapy through bevacizumab: cite documented failure or contraindication if requesting aflibercept/faricimab first-line
- State whether the dosing is loading (monthly × 3) or maintenance (PRN vs treat-and-extend vs fixed)
Drug-specific PA criteria at Highmark
Deep dives on each drug's PA criteria at Highmark:
Frequently asked questions
What documentation does Highmark need for ophthalmology prior authorizations?
Highmark's PA packet for ophthalmology typically includes: Diagnosis with ICD-10 (nAMD, DME, RVO, mCNV); OCT scan with central macular thickness; Fluorescein angiography or OCT-A confirming CNV/leakage where required; Prior anti-VEGF history (drug, doses, intervals, response). AAO (American Academy of Ophthalmology) Preferred Practice Patterns citations strengthen the submission.
What's the turnaround at Highmark?
Highmark standard decision: 30 days. Expedited (urgent care): 72 hours per 45 CFR §147.136. Internal appeal window if denied: 180 days.
Which ophthalmology drugs does Highmark most often PA-restrict?
Top targets in ophthalmology: aflibercept, faricimab, ranibizumab. Each follows the per-drug step therapy + documentation requirements published in Highmark's medical policy library.
How do I prep a peer-to-peer with Highmark in ophthalmology?
Bring the latest OCT scan (printed or open in EHR) Quote the AAO PPP by year + indication Have the policy URL and the patient's chart open before the call.
Generate a Ophthalmology PA packet
Open ApprovalHelp — generate a ophthalmology PA packet tailored to Highmark's criteria, with prescriber attestation and supporting citations pre-filled.
Get started →Contact: hello@approvalhelp.com